what are the revenue recognition steps
what are some complications of revenue recognition
define cost to cost method
recognize revenue
over the life of a long-term contract in amounts that track the percentage of completion of the con-
tract. Companies typically use the percentage of projected contract costs that have been incurred
to estimate the contract’s percentage of completion.
requires an estimate of total costs. This estimate
is made at the beginning of the contract and is typically the one used to bid the contract. However,
estimates are inherently inaccurate. If the estimate changes during the construction period, the per-
centage of completion is computed as the total costs incurred to date divided by the
current
estimate
of total anticipated costs (costs incurred to date plus total estimated costs to complete). Then revenue
recognized for the current period is the difference between total revenue to be recognized to date,
based on the new percentage of completion, and previously recognized revenue.
If total construction costs are underestimated, the percentage of completion is overestimated (the denominator is too low), revenue and gross profit to date are overstated, and the
remaining revenue and gross profit to be recognized in the future is understated. The estimation process inherent in this method has the potential for inaccurate or even improper revenue
recognition. In addition, estimates of remaining costs to complete projects are difficult for the
auditors to verify. This uncertainty adds additional risk to financial statement analysis.
define contract liabilities
another term for deferred or unearned revenue - obligation to deliver the product for which it has been paid
where are sales allowances especially prevalent in
industries with undifferentiated commoditized products
how to record down sales allowances
reduce sales by the amount you expect return to sales to be
what are the steps to an analysis of sales allowance
where is unearned revenue common among companies that
Receive advance payments from customers for products or services not yet delivered.
■
Sell gift cards.
■
Sell memberships or subscriptions.
why do companies frequently hedge their foreign currency exposures using derivatives + derivative securities
These hedging activities act like an insurance policy to offset the income
statement effects of
realized
foreign exchange gains and losses. The derivatives and derivative
securities transfer some of the foreign-currency risk to other parties that are willing to accept that
risk for a fee. An effective hedging strategy reduces the effects of realized gains and losses and
greatly mitigates the impact on net income.
what’s the effect of foreign currency on revenue, expenses and cash flow
foreign currency effects are largely translation effects and not transaction effects as sales contract are written in local currency, not always the currency that the company reports in.
strengthen currency compared to a foreign currency may lead to lower revenues + expenses
there may a change in pretax income but not a change in operation cash flows as business are conducted in local currency
including organic growth rate
define organic growth rate
discuss growth of company in MD&A, organic growth excludes these foreign currency effect/effects of M&A, or opening of new stores for a retailer to isolate the core growth of the company
why do companies use an aging analysis of receivables
to estimate the uncollectible amounts as the aging analysis groups A/R by number of days past due
how to account for A/R
using the allowance of uncollectible accounts (allowance for doubtful accounts) to reduce gross amount of receivables that reported on B/S
what’s an important analysis tool for A/R
to determine the magnitude + quality of the receivables. The relative magnitude of accounts receivable is usually measured with respect
to sales volume using either of the following ratios - A/R turnover and DSO
what can a DSO reveal
DSO reveals the number of days, on average, that accounts receivable are outstanding before they
are paid. The DSO can be:
■
Compared with the company’s established credit terms to investigate if the company’s cus-
tomers are conforming to those credit terms.
■
Computed over several years for the same company to investigate trends. DSO reveals the number of days, on average, that accounts receivable are outstanding before they
are paid. The DSO can be:
■
Compared with the company’s established credit terms to investigate if the company’s cus-
tomers are conforming to those credit terms.
■
Computed over several years for the same company to investigate trends.
why is it not favourable to have A/R grow more quicker than sales
Company is becoming more lenient in granting credit to its customers.
Perhaps this is
in response to greater competition, or perhaps the company is finding it difficult to maintain
sales volume and is reaching for additional volume by selling to new customers with weaker
credit scores.
■
Credit quality is deteriorating.
If existing customers are not paying on time, the level of
accounts receivable relative to the level of sales will increase. This will be highlighted in the
DSO statistic, which will increase as the percentage of receivables to sales grows.
■
Mix of products sold changes with products or customer contracts having longer pay-
ment terms.
In this case, the quality of the receivables is not in question.
how to analyze the quality of a/r
focus on allowance for uncollectible accounts
what are the interpretations to allowance for doubtful accounts decreasing for a company
what are the typical deduction from I/S?
Cost of sales.
This is the cost Pfizer incurred to make or buy the products it sold during the
year. As goods are manufactured or purchased, the cost is recognized as inventory on the
balance sheet. The inventory remains there until the product is sold, at which time the cost is
transferred from the balance sheet into the income statement as cost of goods sold. Given that
the product is sold, revenue from the sale of the product is also added to the income statement.
The difference between revenue and cost of sales is the gross profit on the sale. We discuss
this cost together with inventories in Module 6 and the analysis of the gross profit margin
(Gross profit/Sales) in Module 3.
■
Selling, informational and administrative expense.
Usually, this expense category is
labeled Selling, general and administrative (SG&A) expense, and it includes a number of
general overhead expense categories, such as:
●
Salaries and benefits for administrative personnel and executives.
●
Rent and utilities for office facilities.
●
Marketing and selling expenses.
●
IT, legal, and accounting expenses.
●
Depreciation for Pfizer’s depreciable assets that are used for administrative purposes (we
discuss this expense together with property, plant, and equipment in Module 6).
■
Research and development expense.
This is the amount Pfizer incurs to conduct research
for new products. We discuss this cost in a separate section below.
■
Acquired in-process research and development expenses.
This represents R&D projects
that were in-process at a company that Pfizer acquired. On the acquisition date, Pfizer added
the fair value of the projects to its balance sheet like all other assets acquired. Later, when
Pfizer scaled back or abandoned the projects, the remaining balance sheet value was recog-
nized as an expense on that year’s income statement.
■
Amortization of intangible assets.
When Pfizer acquires an intangible asset, such as a pat-
ent, it amortizes that cost over the useful life of the patent (the period of time Pfizer expects
the patent to produce cash flow). Amortization expense is a noncash expense, similar to
depreciation expense. Often, it is included with the SG&A expense.
■
Restructuring charges.
This represents the cost Pfizer has incurred and expects to incur to
restructure its operations, say, by the elimination of lines of business, consolidation of opera-
tions, reduction of the number of employees, and the like. We discuss restructuring charges
in Module 6.
■
Provision for taxes on income.
The tax provision shown on the income statement relates to
Pfizer’s profit. These are taxes that will be paid to federal and state taxing authorities as well as
income taxes levied by foreign governments and municipalities. We discuss income tax expense
in a separate section below and, in greater depth, in Module 10. Other types of taxes, such as
sales tax or employment taxes, are included in SG&A and not with the income tax expense
■
Discontinued operations.
This represents the operating profit (or loss) plus the gain (or loss)
on the sale of businesses Pfizer has decided to divest.
We discuss discontinued operations in
a separate section below.
■
Income attributable to noncontrolling interest.
Noncontrolling interest arises because
Pfizer has one or more subsidiaries where Pfizer does not own 100% of the voting stock. So,
while Pfizer owns the controlling interest, other shareholders own the balance of the stock
(the noncontrolling interest). The income attributable to the noncontrolling interest is their
portion of the subsidiary’s income (and is added to the noncontrolling interest equity account
on Pfizer’s balance sheet). The remainder of the subsidiary’s net income is credited to Pfizer’s
shareholders and is added to retained earnings on Pfizer’s balance sheet. We discuss noncon-
trolling interest in greater depth in Module 9.
what costs does R&D cost have
■
Salaries and benefits for researchers and developers.
■
Supplies needed to conduct the research.
■
Licensing fees for intellectual property or software used in the R&D process.
■
Third-party payments to collaborators at other firms and universities.
■
Laboratory and other equipment.
■
Property and buildings to be used as research facilities. As we discuss in a later module,
research facilities are include
how to analyze R&D
measure R&D expense in dollar and as a percentage of total revenue - important to compare a company’s R&D sending to its peers (benchmarks)
what’s the challenges for analysts in developing forward looking predictions of a company’s income and cash flow
the challenge for analysts is two-fold; not only must we
estimate the magnitude of future revenues, but we must estimate revenue timing as well. There is
often a considerable lag between when R&D expenditures occur and when the resulting revenue
is earned. But while the income statement might suffer from such lags, the company’s market cap
reflects at least some of the future revenue related to current period R&D expenditure.
what happens when a company acquires in-proces R&D
it records the acquired IPR&D as an asset
on the balance sheet. This is true whether the company purchases the IPR&D outright from
another company or acquires the company that owns the IPR&D. In the latter case, the fair value
of the IPR&D assets is recognized on the acquiring company’s balance sheet just like all other
assets of the acquired company. IPR&D assets represent indefinite-lived intangible assets that are
not amortized until the associated research and development activities are either completed (then,
the intangible assets are amortized over their remaining useful lives) or abandoned (in which case
they are written off in the year of abandonment).
what did TCIA do and its effects
■
Reduced the corporate tax rate from 35% to 21%.
■
Imposed tax on all
future
income earned outside the U.S. even if the cash profits remain abroad.
■
Reduced the repatriation tax on
prior
foreign earnings to 15.5% (from 35%).